Non-covalent modification of thrombolytic agent nattokinase: simultaneous improvement of fibrinolysis activity and enzymatic stability

Abstract

Folic acid modified chitosan (CS-FA) was synthesized and applied to modify Nattokinase (NK), a thrombolytic agent, for better fibrinolysis activity and stability. It provides great opportunities in curing cardiovascular disease (CVD), a leading cause of death globally.